Suppr超能文献

关于开角型青光眼的系统评价和随机对照试验。

Systematic reviews and randomised controlled trials on open angle glaucoma.

机构信息

NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.

London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Eye (Lond). 2020 Jan;34(1):161-167. doi: 10.1038/s41433-019-0687-5. Epub 2019 Dec 3.

Abstract

Evidence for the effectiveness of interventions to prevent the progression of optic nerve damage in open angle glaucoma has evolved over the last 25 years. We describe that evolution through the systematic reviews on various aspects of the topic and how those reviews have highlighted the need for new trials. Though we can be confident that lowering pressure does indeed reduce the risk of progression, we still lack good evidence on the comparative effectiveness of different treatments not so much on lowering pressure but on preventing progression of the disease. This is true for different medicines, types of laser and especially for different surgical interventions. As always there is a need for more research, but this needs to be focussed on key uncertainties using core outcome sets which avoid research waste. Ultimately, our guidelines can be based on sound and comprehensive evidence of effectiveness.

摘要

在过去的 25 年中,已经有证据表明干预措施可以有效预防开角型青光眼视神经损伤的进展。我们通过对该主题各个方面的系统评价来描述这一演变过程,以及这些评价如何突出了开展新试验的必要性。虽然我们可以确信降低眼压确实可以降低进展的风险,但我们仍然缺乏关于不同治疗方法的比较效果的良好证据,这些治疗方法不仅可以降低眼压,还可以预防疾病的进展。不同的药物、激光类型,尤其是不同的手术干预措施都是如此。正如以往一样,需要进行更多的研究,但这项研究需要使用核心结局集来集中解决关键的不确定性问题,以避免研究浪费。最终,我们的指南可以基于有效性的可靠和全面证据。

相似文献

1
Systematic reviews and randomised controlled trials on open angle glaucoma.
Eye (Lond). 2020 Jan;34(1):161-167. doi: 10.1038/s41433-019-0687-5. Epub 2019 Dec 3.
2
Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force.
Ann Intern Med. 2013 Feb 19;158(4):271-9. doi: 10.7326/0003-4819-158-4-201302190-00008.
3
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Peripheral iridotomy for pigmentary glaucoma.
Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD005655. doi: 10.1002/14651858.CD005655.pub2.
5
Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma.
Br J Ophthalmol. 2017 Oct;101(10):1315-1317. doi: 10.1136/bjophthalmol-2016-309695. Epub 2017 Mar 7.
8
Neuroprotection for treatment of glaucoma in adults.
Cochrane Database Syst Rev. 2013 Feb 28;2(2):CD006539. doi: 10.1002/14651858.CD006539.pub3.
9
Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.
BMJ. 2005 Jul 16;331(7509):134. doi: 10.1136/bmj.38506.594977.E0. Epub 2005 Jul 1.
10
Neuroprotection for treatment of glaucoma in adults.
Cochrane Database Syst Rev. 2017 Jan 25;1(1):CD006539. doi: 10.1002/14651858.CD006539.pub4.

引用本文的文献

1
Non-human primates as preclinical models for optic nerve research: advancing insights into their application and potential.
Eye (Lond). 2025 May;39(7):1254-1263. doi: 10.1038/s41433-025-03665-w. Epub 2025 Feb 21.
4
Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma.
Ophthalmol Sci. 2023 Feb 24;3(2):100290. doi: 10.1016/j.xops.2023.100290. eCollection 2023 Jun.
5
Silicone Oil-Induced Glaucomatous Neurodegeneration in Rhesus Macaques.
Int J Mol Sci. 2022 Dec 14;23(24):15896. doi: 10.3390/ijms232415896.
7
The Role of miR-29 Family in TGF-β Driven Fibrosis in Glaucomatous Optic Neuropathy.
Int J Mol Sci. 2022 Sep 6;23(18):10216. doi: 10.3390/ijms231810216.
9
Single-cell transcriptome analysis of regenerating RGCs reveals potent glaucoma neural repair genes.
Neuron. 2022 Aug 17;110(16):2646-2663.e6. doi: 10.1016/j.neuron.2022.06.022. Epub 2022 Aug 10.
10
Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2.
Sci Rep. 2022 Jun 10;12(1):9564. doi: 10.1038/s41598-022-13573-8.

本文引用的文献

1
Ab interno supraciliary microstent surgery for open-angle glaucoma.
Cochrane Database Syst Rev. 2021 May 28;5(5):CD012802. doi: 10.1002/14651858.CD012802.pub2.
2
Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma.
Cochrane Database Syst Rev. 2020 Mar 9;3(3):CD012740. doi: 10.1002/14651858.CD012740.pub2.
3
Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews.
JAMA Ophthalmol. 2019 Jul 1;137(7):775-785. doi: 10.1001/jamaophthalmol.2019.1063.
4
Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma.
Cochrane Database Syst Rev. 2019 Apr 19;4(4):CD011875. doi: 10.1002/14651858.CD011875.pub2.
5
Ab interno trabecular bypass surgery with iStent for open-angle glaucoma.
Cochrane Database Syst Rev. 2019 Mar 28;3(3):CD012743. doi: 10.1002/14651858.CD012743.pub2.
7
Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure.
Cochrane Database Syst Rev. 2019 Feb 25;2(2):CD012741. doi: 10.1002/14651858.CD012741.pub2.
8
Subconjunctival draining minimally-invasive glaucoma devices for medically uncontrolled glaucoma.
Cochrane Database Syst Rev. 2018 Dec 16;12(12):CD012742. doi: 10.1002/14651858.CD012742.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验